Plus Therapeutics reported $7.11M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Baxter International USD 6.04B 2.85B Mar/2026
Cerus USD 34.78M 2.98M Dec/2024
Dr.Reddys Laboratories INR 74.58B 977M Mar/2026
Haemonetics USD 134.99M 1.26M Dec/2025
Infinity Pharmaceuticals USD 10.7M 1.54M Jun/2023
Northwest Biotherapeutics USD -108.65M 8.26M Sep/2025
Plus Therapeutics USD 7.11M 1.23M Dec/2025
Sanofi EUR 9.31B 1.2B Mar/2026
Starpharma Holdings AUD 11.7M 7.69M Dec/2025
Sun Pharmaceuticals INR 114.07B 2.96B Dec/2025
Teva Pharmaceutical Industries USD 3.22B 1000M Mar/2026